Alopecia areata incidence was highest in patients in North America, Southeast Asia, and Australia, as well as in women and those aged 30 to 34 years.

Eli Lilly and Incyte have another rival in the rear-view mirror for Olumiant in alopecia areata after Pfizer reported that its ritlecitinib improved scalp hair regrowth in a late-stage trial.

Alopecia areata is a skin disease that makes you lose patches or large sections of hair on your scalp and body. It's not life-threatening, but it can be life-altering. Hair is a part of your identity.

If you have alopecia areata, you are probably no stranger to a roller coaster of emotions. It’s true that this condition isn’t life-threatening and doesn't cause physical pain. But it can ...

And not to be the bearer of bad news, but doctors and researchers ... they may also be causing a type of hair loss called alopecia areata, an autoimmune condition that "attacks" the hair follicles ...

Guideline for Managing Alopecia Areata (BAD, 2024) 2024 Guideline on the management of alopecia areata from the British Association of Dermatologists, published in the British Journal of Dermatology.

Adolescents with alopecia areata achieve hair regrowth with 80% or more of scalp coverage while taking the Janus kinase inhibitor baricitinib, a phase 3 study finds.

For adolescents with severe alopecia areata (AA), baricitinib is efficacious for hair regrowth, according to a study presented at the annual meeting of the American Academy of Dermatology, held from ...